The synthetic tetrapeptide Epithalon (Ala-Glu-Asp-Gly) activated telomerase and lengthened telomeres in telomerase-negative human fibroblasts, demonstrating anti-aging potential at the chromosomal level.
Telomeres lengthenedEpithalon reactivated telomerase in cells that had none, actually lengthening telomeres — reversing a fundamental aging mechanism at the chromosomal level
What the researchers found
Epithalon peptide (Ala-Glu-Asp-Gly) induced telomerase catalytic subunit (hTERT) expression, telomerase enzymatic activity, and telomere elongation in telomerase-negative human fetal fibroblasts.
Why it matters
Telomere shortening is one of the most fundamental mechanisms of aging. A simple peptide that reactivates telomerase could potentially slow or reverse cellular aging.
How the study worked
In-vitro study adding Epithalon to telomerase-negative human fetal fibroblast cultures. Telomerase catalytic subunit expression, enzymatic activity, and telomere length measured.
What this study cannot tell us
In-vitro fibroblast study. Telomerase activation could promote cancer if uncontrolled. In-vivo effects and safety not assessed. Very short abstract limits detail.
How to read the evidence
Preliminary in-vitro evidence with clear molecular endpoints (hTERT expression, telomerase activity, telomere length) in a defined cell system.
When this study was published
Published in 2003. Epithalon has been studied further in animal longevity models with intriguing results, though clinical evidence remains limited.
The bigger picture
Anti-aging research targets telomere biology as one of aging's root causes. A peptide that safely activates telomerase could represent a practical anti-aging intervention — if safety concerns (cancer risk from unlimited cell division) can be managed.
Questions still open
- Does Epithalon increase cancer risk through telomerase activation?
- Can systemic Epithalon administration slow aging in animals?
- What is the optimal dose and duration for anti-aging benefits?
Common questions
Can a peptide reverse aging?
Is this safe?
Read the original research
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.
Bulletin of experimental biology and medicine, 135(6), 590-2
Citation
Khavinson, V Kh; Bondarev, I E; Butyugov, A A. (2003). Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.. Bulletin of experimental biology and medicine, 135(6), 590-2.